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1. Introduction 
Islets of Langerhans respond to a rapid and con- 
stant increase of the glucose concentration with 
biphasic release of insulin, a pattern that is observed 
in the portal vein in humans [l ] and in isolated pan- 
creatic preparations [2-41. The presence of extracel- 
lular Ca” has been thought essential for both phases 
of insulin release [2,5,6]. However, recent studies 
have suggested that the first phase is dependent upon 
the utilization of cellular calcium, whereas the second 
phase depends both on cellular calcium and increased 
uptake of Ca2+ from the extracellular fluid [3,7], 
Those experiments were performed using either inhib- 
itors of Ca2* uptake [3] or islets with increased cal- 
cium stores [7]. In islets with normal calcium stores, 
a preserved first phase insulin release in the absence 
of extracellular Ca2+ has not been demonstrated. This 
study was performed to examine the differential 
sensitivity of the two phases to Cap deprivation. It
was found that first phase insulin release could occur 
in the absence of extracellular Ca2+, when Ca2* was 
removed from the medium before the glucose-induced 
rise of insulin release. 
2. Materials and methods 
Collagenase isolated rat islets [8] were maintained 
for 46 h in tissue culture medium 199, containing 
1.8 mM CaC12 and 8.3 mM glucose [9 I.40 islets/ 
chamber were perifused as in [5,9]. The chamber 
volume was 70 ~1 and the flowrate 1.2 ml/min 
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which results in a turnover of 17 chamber vol./mm 
The standard perifusion medium consisted of Krebs- 
Ringer bicarbonate buffer (KRB) containing 1 .O mM 
CaC12, 0.5% dialysed bovine serum albumin and glu- 
cose concentrations as indicated. At different time 
points the perifusate was changed to a KRB buffer 
prepared without the addition of CaC12 (Ca’+- 
deprived medium). The total Ca2+ concentration of 
this medium was 14.0 f 1 .l PM (n = 3) as determined 
by atomic absorption spectrophotometry. When 
Ca2+ was removed the measured CaZ* concentration 
decreased from 1 mM to basal values (14.6 f 2.0 (uM, 
n = 5) in the sample collected uring the second 
minute. Assuming an exponential decay curve for the 
decrease it can be calculated from the measured Caa’ 
concentration over the first minute (63.8 ? 2.0 PM, 
n = 5) that the concentration surrounding the islets 
was <25 PM 15 s after the change. Insulin was deter- 
mined by radioimmunoassay [lo] using a rat stan- 
dard. Insulin release values for every single chamber 
during first and second phase were calculated by 
integrating first 5 min of stimulation or the sub- 
sequent 39 mm for first and second phase, respective- 
ly, after individual baseline subtraction. The sources 
of the materials have been described [3]. Data given 
as means + SEM were analysed by Student’s unpaired 
t-test. 
3. Results 
Glucose at 16.7 mM elicited a biphasic insulin 
release at 1 mM Ca2+ throughout (fig.1). One minute 
after high glucose had reached the islets, insulin 
release started to rise, a peak was reached at 2-3 min. 
A nadir at 5-7 min was followed by an increasing 
second phase. Total release above baseline during 
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Flg.1. Effect of Ca*+ removal on glucoseinduced insulin 
release. Islets were perlfused for 46 min with a medium con- 
taining 2.8 mM glucose and 1 mM Cap and then stimulated 
for 44 min with 16.7 mM glucose. Ca”+ deprived medium was 
imposed either simultaneously with 16.7 mM glucose or 1 
min later as indicated. No. obs. in parenthesis. G, glucose. 
first phase (5 min) was 117 f 16 pg/islet and 1494 + 
177, n A 9, during second phase. When islets were 
exposed to Ca2+ deprived medium (14 PM) simulta- 
neously with the increase in the glucose concen- 
tration (1 min before the rise in insulin release) insulin 
release was markedly inhibited during both phases. 
Release was 3 1 + 4 pg/islet during first phase and 
225 + 87 pglislet (n = 7) during second phase, an 
inhibition of 74% and 85% when compared with the 
situation at 1 mM Ca2+ (p < 0.001 for both). 
Next, Ca” was removed 1 min after the increase of 
the glucose concentration, immediately before a signif- 
icant rise in insulin release. Insulin release increased 
markedly despite the simultaneous decrease of the 
Ca2’ concentration. Compared with islets perifused at 
normal Ca2+, there were no significant differences in 
the rate of insulin release until the 5 1 st minute, i.e ., 
5 min after glucose stimulation. Insulin release above 
baseline during first phase (101 + 12 pg/islet, n = 7) 
was similar to that at 1 mM Ca2+ (p > 0.40). In con- 
trast, second phase insulin release was markedly 
inhibited (240 * 113 pg/islet) and was similar to Ca2+ 
removal at the time of glucose stimulation. 
Two control experiments were performed (fig.2). 
To see whether Ca2’ removal per se could cause a 
transient stimulation of insulin release Ca2+ was 
removed in the continuous presence of 2.8 mM glu- 
cose. No change in insulin release occurred. To test 
the effect of Ca2+ deprivation during second phase 
Ca” was omitted after 60 min perifusion, i.e., 14 min 
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Fig.2. Effect of Ca*+ removal during second phase insulin 
release. Islets were perifused for 46 min with 2.8 mM du- 
case and 1 mM Ca*‘. One group was then stimulated for 
44 min with 16.7 mM glucose (continuous line). At the 60th 
min the islets were exposed to Ca’+-deprived medium. Islets 
not subjected to Ca*+ removal are represented by the inter- 
rupted line. Another group of islets was exposed to Cal+- 
deprived medium at 46 min in the continued presence of 
2.8 mM glucose (shaded area). G, glucose. 
after glucose stimulation. Insulin secretion decreased 
promptly in the first min after Ca2+ removal and 
reached a plateau level between 2 and 3 min with 
release rates above basal. Thus, both control experi- 
ments show that Ca2+ removal per se did not stimulate 
insulin release. 
4. Discussion 
An increased concentration of ionised Ca2+ in the 
p-cell cytosol is thought to mediate glucose-stimulated 
insulin release [3,4,11,12]. Such an increase could 
result from a change in the distribution of cellular 
calcium or from increased uptake of Ca2* from the 
extracellular fluid or both. Although glucose enhances 
Ca2+ uptake during first phase insulin release [3,9,12] 
blockade of this stimulated uptake by verapamil did 
not affect the first phase, while second phase release 
was inhibited by 50% [3]. It was therefore concluded 
that the first phase is not dependent on increased 
Ca2+ uptake, but rather on cellular calcium. Further- 
more, islets with increased cellular calcium stores 
perifused at low extracellular Ca2+ (0.1 mM) showed 
a well preserved first phase and a 50% inhibited 
second phase [7]. 
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The failure of glucose to elicit insulin release after 
prolonged absence of Ca2’ [2,.5,6] seems at variance 
with the above conclusion. Moreover, in the present 
study, both phases ‘Df insulin release were markedly 
reduced when Ca2+ was removed at the time of glu- 
case stimulation. Ca’+ deprivation, however, has at 
least two effects on the islets. Influx of extracellular 
Ca2+ isminimized and cellular calcium is decreased 
[5,11,13]. This impliesan imbalance ofCa”influx 
and efflux which combined with the high turnover 
of Ca2+ across the plasma membrane f3] could 
rapidly affect insulin release. For instance, ahypo- 
thetical abile calcium pool in close proximity to the 
P-cell membrane may be of critical importance for 
insulin release [6,11]. An increased amount of pyro- 
antimonate precipitates (presumably containing cal- 
cium) was found at the inside of the plasma mem- 
brane 3 min after exposure to glucose [131. This was 
not seen when Ca2+ was omitted at the time of glu- 
cose stimulation [131. The marked inhibition of 
insulin release under similar conditions in the present 
study could be due to an inability of glucose to raise 
cytosolic Ca” either directly or indirectly because 
within 1 min depletion of a critical calcium pool 
occurs. This was further examined by introducing 
Ca2+ deprived medium 1 min after the start of glucose 
stimulation, i.e., before a significant rise of insulin 
release. Despite the rapid decrease of extracellular 
Ca* (see section 2) a marked increase of insulin 
release resulted and a normal first phase was seen. 
Clear differences exist between the extra- and 
intracellular Ca2+ requirements of first and second 
phase as shown by the results of Ca2* removal just 
discussed and those performed uring second phase, 
in which only a rapid decrease of insulin release 
occurred (fig.2). This is in accord with conclusions 
that second phase insulin release is more dependent 
on extracellular Ca2’ than first phase [3,7]. 
In view of the apparent difference in the regula- 
tion of the two phases of insulin release it is of interest 
that in certain types of human diabetes, p~ticularly 
the early insulin response to glucose is defective 
[ 14,151. It is noteworthy that in the diabetic Chinese 
hamster adefect in cellular Ca’* handling appears to 
be involved in the impaired insulin release [161 and 
that this defect seems to affect mainly the early 
insulin response [16,17]. 
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